BVS
Bioventus Inc
12.90$
+2.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.4% | +8.2% | +6.4% | +9.3% | +6.6% | -5.6% | +34.2% | +18.8% | +0.0% | +11.9% | -0.9% | |
| – | -0.4% | +22.9% | +0.8% | -8.6% | +8.0% | -3.6% | +46.3% | +41.2% | +1.7% | +0.5% | +0.3% | |
| – | +6.6% | +2.1% | +9.2% | +17.5% | +6.0% | -6.3% | +29.6% | +9.4% | -0.9% | +18.3% | -1.5% | |
| – | +55.8% | -46.4% | +2.5% | 0.0% | +36.6% | +1.3% | +70.0% | +25.3% | -43.6% | +1.4% | -11.2% | |
| – | – | – | – | – | +2.3% | -3.0% | +31.6% | +30.6% | -8.2% | +7.5% | -2.7% | |
| – | +5.0% | -3.2% | +2.8% | +21.1% | +4.1% | -2.6% | +36.9% | +71.5% | -17.7% | -2.4% | -19.1% | |
| – | -83,040.0% | – | +81.5% | -5.6% | +22.3% | -31.9% | -43.2% | -1,486.6% | – | – | – | |
| – | +18.9% | +12.0% | +18.6% | +1.4% | +12.6% | -54.8% | -88.6% | +981.0% | +238.4% | -4.6% | -31.7% | |
| – | – | – | – | -29.5% | +58.7% | +64.2% | -40.4% | -2,092.3% | – | – | – | |
| – | +38.3% | -49.0% | -172.0% | – | -5.3% | -24.4% | -264.9% | – | – | -6,327.1% | – | |
| – | – | – | – | – | – | +139.5% | +18.1% | -919.1% | – | – | – | |
| – | +31.8% | +14.0% | +35.9% | -8.9% | +13.0% | -11.8% | -16.3% | -367.4% | – | – | +152.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.